We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-6.95%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.11B
AUM Growth
-$244M
(-18%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-11.97%
Top 10 Holdings %
Top 10 Hldgs %
3.48%
Holding
2,176
New
618
Increased
465
Reduced
510
Closed
580
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSX Corp
CSX
|
+$4.82M |
| 2 |
Blackstone
BX
|
+$4.54M |
| 3 |
Tandem Diabetes Care
TNDM
|
+$3.82M |
| 4 |
Cal-Maine
CALM
|
+$3.17M |
| 5 |
Ziff Davis
ZD
|
+$3.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$97.2M |
| 2 |
NVIDIA
NVDA
|
+$7.97M |
| 3 |
Microsoft
MSFT
|
+$7.34M |
| 4 |
Amazon
AMZN
|
+$7.07M |
| 5 |
Costco
COST
|
+$6.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.36% |
| 2 | Financials | 14.89% |
| 3 | Technology | 13.64% |
| 4 | Consumer Discretionary | 13.03% |
| 5 | Industrials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Pliant Therapeutics
PLRX
$65M
| $47K | ﹤0.01% |
+34,672
| New | +$210K |
|
1552
Greenland Technologies Holding
GTEC
$14.3M
| $45K | ﹤0.01% |
+25,916
| New | +$48.7K |
|
1553
System1
SST
$17.5M
| $45K | ﹤0.01% |
+11,871
| New | +$72.9K |
|
1554
Marqeta
MQ
$1.66B
| $44K | ﹤0.01% |
2,653
-87,996
| -97% | -$1.39M |
|
1555
Perfect Corp
PERF
$196M
| $44K | ﹤0.01% |
+23,601
| New | +$51.4K |
|
|
TOUR
1556
Tuniu
TOUR
$55.6M
| $44K | ﹤0.01% |
+4,012
| New | +$41.3K |
|
1557
Exagen
XGN
$166M
| $44K | ﹤0.01% |
+12,287
| New | +$46.4K |
|
1558
Clarus
CLAR
$143M
| $42K | ﹤0.01% |
+11,217
| New | +$50.3K |
|
|
CLPR
1559
Clipper Realty
CLPR
$46.2M
| $42K | ﹤0.01% |
+10,962
| New | +$46K |
|
1560
Lightwave Logic
LWLG
$1.25B
| $41K | ﹤0.01% |
+39,842
| New | +$62.1K |
|
1561
Babcock & Wilcox
BW
$1.39B
| $40K | ﹤0.01% |
59,112
-674,318
| -92% | -$834K |
|
|
LFT
1562
Lument Finance Trust
LFT
$36.6M
| $37K | ﹤0.01% |
+14,329
| New | +$38.3K |
|
1563
AEye
LIDR
$61.1M
| $35K | ﹤0.01% |
+61,495
| New | +$57.9K |
|
|
EQC
1564
DELISTED
Equity Commonwealth
EQC
| $35K | ﹤0.01% |
21,467
-255,500
| -92% | -$430K |
|
|
HLVX
1565
DELISTED
HilleVax
HLVX
| $34K | ﹤0.01% |
23,552
-44,277
| -65% | -$81.8K |
|
1566
Smart Sand
SND
$194M
| $34K | ﹤0.01% |
+12,984
| New | +$30.5K |
|
|
STLN
1567
Starling Oncology, Inc. Common Stock
STLN
$641M
| $33K | ﹤0.01% |
+28,529
| New | +$22.1K |
|
1568
Cardlytics
CDLX
$21.5M
| $32K | ﹤0.01% |
1,731
-29,441
| -94% | -$841K |
|
1569
Ampco-Pittsburgh
AP
$193M
| $31K | ﹤0.01% |
+14,171
| New | +$31.3K |
|
1570
SEALSQ Corp
LAES
$573M
| $31K | ﹤0.01% |
+11,948
| New | +$44.7K |
|
1571
One Stop Systems
OSS
$330M
| $30K | ﹤0.01% |
+13,127
| New | +$44K |
|
1572
Kaixin Holdings
KXIN
$8.76M
| $29K | ﹤0.01% |
+69
| New | +$39.7K |
|
1573
Zura Bio
ZURA
$566M
| $29K | ﹤0.01% |
22,702
+12,150
| +115% | +$19.2K |
|
1574
CuriosityStream
CURI
$161M
| $28K | ﹤0.01% |
+10,360
| New | +$25.2K |
|
|
PVL
1575
Permianville Royalty Trust
PVL
$57.1M
| $27K | ﹤0.01% |
+17,570
| New | +$26.1K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2025 Portfolio in Review
As of Q1 2025, GSA Capital Partners held 2,176 positions worth $1.11B, down 18% from $1.35B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
GSA Capital Partners withdrew a net $132M in Q1 2025, closing 580 positions and reducing 510 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $97.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Financials and Technology.
Against the trend, GSA Capital Partners opened a new position in CSX Corp worth $4.46M.
- GSA Capital Partners's largest Q1 2025 buy was CSX Corp: 151,729 shares worth $4.46M.
- GSA Capital Partners added most to Blackstone in Q1 2025, an estimated $4.54M increase.
- GSA Capital Partners's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $7.97M.
- GSA Capital Partners fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $97.2M.
- GSA Capital Partners's ten largest holdings make up 3.5% of its $1.11B portfolio in Q1 2025.
- GSA Capital Partners opened 618 new positions and closed 580 in Q1 2025.
- GSA Capital Partners's portfolio value fell 18% quarter-over-quarter to $1.11B.
Based on GSA Capital Partners's 13F filing for Q1 2025, filed 8 May 2025.